S2-E7.3 – The newer diabetes drugs and NASH: Educating and Motivating Stakeholders

The panelists consider the barriers to bringing NASH into central consciousness in diabetes therapy and some keys to success.

Louise Campbell and Roger Green discuss issues and challenges in educating diabetic patients about NAFLD and NASH. Louise discusses how the rising amount of mortality tied to liver cancer should create a new urgency to broaden focus about the role the liver plays in metabolic health. Roger raises the role that reference labs like Quest and LabCorp have played in driving awareness of underappreciated diseases. The group has several ideas and avenues to explore. Listeners take heed…we have much to figure out and do.

Experience Nudge Learning! Interested in a new way of learning?